Releases Geral
EAACI Congress Kicks Off in Valencia, Spain
AGÊNCIA DE COMUNICAÇÃO Conteúdo de responsabilidade da empresa 31 de maio de 2024
European Academy of Allergy and Clinical Immunology
VALENCIA, Spain, May 31, 2024 (GLOBE NEWSWIRE) — The EAACI International Congress has commenced with the slogan Revolutionizing patient care through the power of data science. Over the next four days, experts will discuss the latest advancements in this impactful area. Allergies, which represent a significant public health issue, encompass a variety of conditions.
Drug allergy is a major adverse reaction that can have serious consequences. Antibiotics, particularly penicillin and its derivatives, are the drugs that most frequently cause allergic reactions, says Maria Jose Torres, Secretary General of EAACI. NSAIDs, radiological contrast media, and chemotherapeutics are also responsible for a significant proportion of reactions, she details.
Asthma, especially when combined with obesity, has a considerable impact on quality of life if not properly managed. These two prevalent health conditions significantly affect people’s quality of life, stresses André Moreira, Co-Chair of the Congress Scientific Program.
Another major topic is the progress made in the treatment of allergies. As Stefano Del Giacco, President of EAACI, explains, In the field of precision medicine, identifying genetic variants associated with increased susceptibility to allergies and using specific biomarkers have improved the management of some types of allergies, allowing the development of more personalised treatments.
We are achieving excellent results in the application of immunotherapy for allergic rhinitis and asthma, says Mübeccel Akdis, Co-Chair of the Congress Scientific Program. This also applies to food allergies, with oral therapy or the personalisation of vaccines based on the patient’s immunological profile.
Big Data in Allergology enables the collection and analysis of large amounts of clinical, genetic, and environmental data, which are used to identify risk factors and allergy patterns, notes Mohamed Shamji, Vice President of the EAACI Congress. AI enhances allergy diagnosis through advanced analysis of clinical data and plays a crucial role in developing new treatments by identifying therapeutic targets and optimizing molecules. We are at a time of great and promising advances, though not without challenges, concludes Shamji.
Press Contact EAACI
+41 44 205 55 33
communications@eaaci.org
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/a7b50aa2-2473-4832-9ed0-73a70d86d865
A OESP nao e(sao) responsavel(is) por erros, incorrecoes, atrasos ou quaisquer decisoes tomadas por seus clientes com base nos Conteudos ora disponibilizados, bem como tais Conteudos nao representam a opiniao da OESP e sao de inteira responsabilidade da GlobeNewswire
Leia também
-
Releases Geral STF suspende concursos por limitação de vagas para mulheres
11 de abril de 2024(DINO - 11 abr, 2024) - Uma decisão da Justiça suspendeu concursos da PM (Polícia Militar) e do Corpo de Bombeiros no DF (Distrito Federal) e em nove estados
Saiba Mais -
Releases Geral FreedomPay and Toast Survey Reveals Top Priorities for Enterprise Hospitality Leaders: Data Security, Integration, and Growth Enablement
25 de junho de 2024Philadelphia, Pennsylvania, June 25, 2024 (GLOBE NEWSWIRE) -- A recent survey conducted by FreedomPay, a global leader in Next Level Commerce solutions, in collaboration
Saiba Mais -
Releases Geral IA pode aumentar empregabilidade de pessoas com deficiência
16 de novembro de 2023DINO DIVULGADOR DE NOTÍCIAS São Paulo–(DINO – 16 nov, 2023) – Enquanto se discute os riscos da Inteligência Artificial (AI) na extinção de cargos de trabalho em nível global
Saiba Mais